One of the most commonly mutated genes in non-small-cell lung cancer is nuclear factor erythroid 2-related factor 2 (NRF2), which drives oncogenic progression in this context in part by activating NQO1 transcription, thereby increasing superoxide scavenging33. This evidence concerns the gene NQO1 and non-small cell lung carcinoma.